AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1514711
Drug: nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: nifedipine SR 20-40 mg twice daily
Trial: 30200162
Drug: Adjunct intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunct intermittent pneumatic compression with pharmacologic thromboprophylaxis
Trial: 24383508
Drug: Carbohydrate ingestion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate ingestion throughout (CC)
Trial: 20851295
Drug: Folate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Folate (5 mg) plus vitamin B12 (500 μg) supplementation
Trial: 24903195
Drug: Intra-aortic Balloon
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-aortic Balloon Pump (IABP) therapy
Trial: 24903195
Drug: No IABP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No IABP therapy (Control)
Trial: 15803031
Drug: Infliximab (maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (maintenance therapy)
Trial: 15803031
Drug: Infliximab (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (first dose)
Trial: 7848022
Drug: Cholestyramine resin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine resin, 8 g/d
Trial: 7848022
Drug: Cholestyramine resin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine resin, 8 g/d plus lovastatin, 5 mg/d
Trial: 21560649
Drug: Alternative anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative anti-inflammatory drug based on ginger extract
Trial: 15003074
Drug: Lamotrigine (100-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (100-500 mg/day)
Trial: 9779760
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment with bacteriologic eradication
Trial: 9779760
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment without bacteriologic eradication
Trial: 9676769
Drug: Tramadol (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (250 mg/day)
Trial: 9676769
Drug: Tramadol (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (50-100 mg every 4-6 h as needed for pain)
Trial: 2561281
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (S)
Trial: 30952531
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy (ET) including mechanical thrombectomy (MT) alone (N = 269), MT ± thrombolysis (N = 297), and thrombolysis alone (N = 682)
Trial: 23926685
Drug: Control (testosterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (testosterone undecanoate capsules)
Trial: 16952675
Drug: 0.8 mg
RxNorm normalized name: biotin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg tamsulosin daily
Trial: 9131726
Drug: Doxepin administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin administered intravenously (125 mg) switched to oral administration (250 mg)
Trial: 7641549
Drug: Laparoscopic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic treatment (totally pre-peritoneal approach)
Trial: 2567717
Drug: Progesterone vaginal
RxNorm normalized name: progesterone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone vaginal suppositories (PVS)
Trial: 31907828
Drug: acarbose 50
RxNorm normalized name: acarbose 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acarbose 50 mg for 1 week
Trial: 31907828
Drug: sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sitagliptin 100 mg for 1 week
Trial: 31907828
Drug: verapamil 120
RxNorm normalized name: verapamil 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 120 mg for 1 week
Trial: 31907828
Drug: liraglutide 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liraglutide 1.2 mg for 3 weeks
Trial: 31907828
Drug: pasireotide 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pasireotide 300 μg as a single dose
Trial: 31144430
Drug: baseline period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: baseline period without treatment
Trial: 28608641
Drug: Intensive immunosuppressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive immunosuppressive regimen (including ATG, steroid therapy, high CNI doses)
Trial: 21526229
Drug: Daily micronutrient-rich
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily micronutrient-rich nutritional supplement
Trial: 21526229
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (nutritional supplement and physical activity)
Trial: 18843004
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein intake containing 99 mg isoflavones daily
Trial: 8759268
Drug: Sulphapyridine 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulphapyridine 500 mg twice daily
Trial: 28838010
Drug: Supplemental oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental oxygen (O2) at 10 L/min via facemask
Trial: 27412188
Drug: Control (discontinue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (discontinue all hypertensive medications)
Trial: 18923311
Drug: Manual physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual physical therapy and exercise (MTE)
Trial: 12519101
Drug: Quetiapine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine therapy
Trial: 7769807
Drug: Enalaprilat 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat 0.25 mg/h
Trial: 7769807
Drug: Enalaprilat 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat 0.5 mg/h
Trial: 2022712
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 10-amino acid mixture
Trial: 7066166
Drug: Spironolactone 200
RxNorm normalized name: Spironolactone
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone 200 mg
Trial: 26281178
Drug: Livodexa (Sun
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Livodexa (Sun Pharmaceutical Industries Ltd, India)
Trial: 11152850
Drug: High-dose simvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose simvastatin
Trial: 9890203
Drug: Isoproterenol, acetylcholine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol, acetylcholine, and nitroglycerin (dosage not specified)
Trial: 7905097
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow infusion after a 10 day course of antithymocyte globulin, 5 days post-transplantation.
Trial: 7905097
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not specified what treatment they received).
Trial: 7905097
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow infusion group.
Trial: 23917673
Drug: Methadone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (5 mg bid)
Trial: 19035101
Drug: TACE +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACE + HITT therapy
Trial: 19035101
Drug: TACE +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACE + PEI only therapy
Trial: 11032201
Drug: Enhanced back
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enhanced back care plus manual therapy
Trial: 8330997
Drug: 1.6 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 Gy twice daily, 5 days a week, with total brain treatment to 32.0 Gy and boost doses escalating from 16.0 Gy to 42.40 Gy.
Trial: 3299287
Drug: Porcine insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine insulin (group A)
Trial: 3299287
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (group C)
Trial: 20397458
Drug: Hormone block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone block therapy and drug medication
Trial: 18680246
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dexrabeprazole daily
Trial: 18680246
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg rabeprazole daily
Trial: 16185308
Drug: Oxytocin treatment
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin treatment (nasal inhalation, twice daily for 13 weeks)
Trial: 16185308
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (nasal inhalation, twice daily for 13 weeks)
Trial: 14986908
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education program and supervised tooth brushing with fluoridated toothpaste (1100 ppm F‐) in test group (n = 258)
Trial: 14986908
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 256) with no oral health education and no supervised tooth brushing
Trial: 10634838
Drug: Trophic feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trophic feeding (0.5‐1 ml/h) along with parenteral nutrition
Trial: 6489151
Drug: High methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High methadone dose increase to 60 mg in week 4, then gradual reduction to 30 mg by week 10.
Trial: 6489151
Drug: Constant 30
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant 30 mg methadone dose through treatment week 10.
Trial: 6489151
Drug: High methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High methadone dose increase group (experimental)
Trial: 6489151
Drug: Constant 30
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant 30 mg methadone dose group (control)
Trial: 30157839
Drug: Pretreatment educational
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pretreatment educational programme followed by treatment as usual
Trial: 27155741
Drug: Pictilisib (340
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pictilisib (340 mg in part 1; 260 mg in part 2) plus fulvestrant 500 mg
Trial: 27155741
Drug: Pictilisib (340
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pictilisib (340 mg in part 1; 260 mg in part 2)
Trial: 22416676
Drug: Treatment Interruption
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment Interruption (TI) arm
Trial: 22416676
Drug: Treatment Continuation
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment Continuation (TC) arm
Trial: 12216432
Drug: Oral continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral continuous 17-beta estradiol and norethindrone acetate
Trial: 12216432
Drug: Transdermal cyclic
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal cyclic 17-beta estradiol and norethindrone acetate
Trial: 7887385
Drug: Fosinopril 10
RxNorm normalized name: fosinopril 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril 10 or 20 mg/day
Trial: 2532927
Drug: Terbinafine (SF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine (SF 86-327, Lamisil) 250 mg daily for 6 months (finger-nail) and 12 months (toe-nail)
Trial: 2532927
Drug: Terbinafine (SF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine (SF 86-327, Lamisil) 250 mg daily
Trial: 57520
Drug: Alice strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alice strain live influenza vaccine
Trial: 28931617
Drug: Normobaric hyperoxia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normobaric hyperoxia (NBO) treatment (100% O2) in rats during middle cerebral artery occlusion.
Trial: 28931617
Drug: Normobaric hyperoxia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normobaric hyperoxia (NBO) treatment in patients with AIS receiving intravenous tPA thrombolysis.
Trial: 23494931
Drug: Sildenafil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil plus testosterone gel (n=70)
Trial: 23494931
Drug: Sildenafil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil plus placebo gel (n=70)
Trial: 21081772
Drug: Conventional promotility
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional promotility drug treatment group (DTG; metoclopramide, cisapride, erythromycin)
Trial: 21081772
Drug: Conventional promotility
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional promotility drugs
Trial: 10818079
Drug: Fasidotril (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasidotril (100 mg twice daily for 6 weeks)
Trial: 8895272
Drug: Droperidol 0.625
RxNorm normalized name: droPERidol 0.625 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 0.625 mg
Trial: 6133103
Drug: Advice on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advice on cholesterol-lowering diet, smoking cessation, weight control, exercise, and treatment of hypertension.
Trial: 30625070
Drug: Caplacizumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caplacizumab (10 mg intravenous loading bolus, followed by 10 mg daily subcutaneously)
Trial: 12131314
Drug: 3.9 mg
RxNorm normalized name: menthol 3.9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.9 mg daily oxybutynin TDS
Trial: 12131314
Drug: 2.6 mg
RxNorm normalized name: menthol 2.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.6 mg daily oxybutynin TDS
Trial: 10102962
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (1 g sucralfate q.d.s. for 28 days, 300 mg metronidazole q.d.s. for 14 days, 250 mg clarithromycin q.d.s. for 14 days)
Trial: 10102962
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg q.d.s. for 12 months)
Trial: 2262904
Drug: Zolpidem (15,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (15, 30 and 45 mg)
Trial: 2262904
Drug: Triazolam (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.25, 0.5 and 0.75 mg)
Trial: 30324837
Drug: 1 mg/day estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day estradiol valerate plus 4 mg/day medroxyprogesterone acetate on days 19‐30 (Group A)
Trial: 30324837
Drug: 1 mg/day estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day estradiol valerate plus 100 mg/day micronized progesterone on days 19‐30 (Group B)
Trial: 30324837
Drug: Cimicifuga foetida
RxNorm normalized name: Ballota foetida extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimicifuga foetida extract, 1 tablet (contains 33.3 mg extract), t.i.d. (Group C)
Trial: 30022759
Drug: Pidotimod oral
RxNorm normalized name: pidotimod Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pidotimod oral liquid
Trial: 30022759
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (ganciclovir for injection and symptomatic treatment)
Trial: 27030629
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (C)
Trial: 25377429
Drug: Pregabalin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 2.5 mg/kg/day
Trial: 25377429
Drug: Pregabalin 15
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 15 mg/kg/day
Trial: 25377429
Drug: Pregabalin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (up to 10 mg/kg/day for ages 1 month to 16 years; up to 15 mg/kg/day for ages <6 years)
Trial: 21512813
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (10 mg/kg intravenously before tourniquet inflation and 3 hours postoperatively; 250 mg orally, two capsules three times daily for 5 days)
Trial: 16060124
Drug: Torsemide (29
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torsemide (29 mg, range 0-160 mg) every 6 h
Trial: 16060124
Drug: Furosemide (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (60 mg, range 0-240 mg) every 6 h
Trial: 2277569
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose epidural morphine (2 mg) and 75 mg diclofenac sodium i.m. postoperatively (Group B)
Trial: 2277569
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose epidural morphine (2 mg) and 3 ml normal saline i.m. at recovery room (Group A)
Trial: 316976
Drug: Prophylactic propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic propranolol treatment postoperatively
Trial: 316976
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of intravenous propranolol therapy
Trial: 29016626
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitor (PPI)
Trial: 29016626
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of PPI
Trial: 29016626
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of PPI
Trial: 15521106
Drug: Penicillin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin (800 mg/day)
Trial: 15521106
Drug: Diethylcarbamazine (DEC;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC; 1 mg/kg.day)
Trial: 15521106
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of penicillin and DEC (at the same doses)
Trial: 15521106
Drug: Framycetin ointment
RxNorm normalized name: framycetin
DrugBank: Framycetin (DB00452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Framycetin ointment
Trial: 15521106
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets and placebo ointment
Trial: 9684133
Drug: Multivitamin infusion
RxNorm normalized name: multivitamin infusion, adult no.2 without vit K
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin infusion (Omnibionta) including 10 mg of alpha‐tocopherol acetate, 2 mg of DL‐alpha‐tocopherol, and 1 g of ascorbate
Trial: 9684133
Drug: Multivitamin infusion
RxNorm normalized name: multivitamin infusion, adult no.2 without vit K
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin infusion (Omnibionta)
Trial: 8390768
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antioxidant treatment)
Trial: 3072356
Drug: Ketoprofen 300
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen 300 mg
Trial: 3072356
Drug: Aspirin 650
RxNorm normalized name: aspirin 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 650 mg plus Codeine 60 mg
Trial: 30265306
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg progesterone vaginal pessaries bid
Trial: 30265306
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg progesterone vaginal pessaries bid
Trial: 30265306
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg progesterone vaginal gel od
Trial: 30265306
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg progesterone vaginal pessaries bid
Trial: 30265306
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg progesterone vaginal pessaries od
Trial: 28699555
Drug: Control Clusters
RxNorm normalized name: cluster fig extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Clusters (CC)
Trial: 16464703
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Group Therapy for Adolescents (CBGT‐A)
Trial: 16464703
Drug: Social Effectiveness
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social Effectiveness Therapy for Adolescents‐‐Spanish version (SET‐Asv)
Trial: 16464703
Drug: Intervención en
RxNorm normalized name: Salazopyrin EN
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervención en Adolescentes con Fobia Social‐‐Treatment for Adolescents with Social Phobia (IAFS)
Trial: 11704914
Drug: Gd-EOB-DTPA (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gd-EOB-DTPA (3, 6, 12.5, 25, and 50 micromol/kg b. w. as a bolus injection)